AUTOBAHN THERAPEUTICS
Autobahn Therapeutics is focused on improving life health for people affected by CNS disorders. Autobahn is leveraging a deep understanding of validated human biology coupled with its brain-targeting chemistry platform to develop thyroid hormone receptor beta agonist therapies that harness the regenerative power of the human body. The companyโs pipeline is led by ABX-002 for the treatment of multiple sclerosis and adrenomyeloneuropathy (AMN), a rare genetic disorder. Autobahn Therapeutics is based in San Diego.
AUTOBAHN THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2017-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.autobahntx.com
Total Employee:
11+
Status:
Active
Contact:
+1 858 722-0037
Email Addresses:
[email protected]
Total Funding:
208.7 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF WordPress LetsEncrypt SSL By Default Organization Schema Sitelinks Search Box Yoast WordPress SEO Plugin Nginx
Similar Organizations
Aardvark Therapeutics
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.
Alloy Therapeutics
Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services.
Aspect Biosystems
Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.
Engrail Therapeutics
Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.
Neurogene
Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.
Biosplice Therapeutics
Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.
Sana Biotechnology
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Sanofi
Sanofi is engaged in the research, development, manufacturing, and marketing of innovative therapeutic solutions.
Tenaya Therapeutics
Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.
VenoStent
VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.
Current Employees Featured
Founder
Investors List
GT Healthcare Capital Partners
GT Healthcare Capital Partners investment in Series C - Autobahn Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series C - Autobahn Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series C - Autobahn Therapeutics
BVF Partners
BVF Partners investment in Series C - Autobahn Therapeutics
Monograph Capital
Monograph Capital investment in Series C - Autobahn Therapeutics
Insight Partners
Insight Partners investment in Series C - Autobahn Therapeutics
Newpath Management
Newpath Management investment in Series C - Autobahn Therapeutics
Canaan Partners
Canaan Partners investment in Series C - Autobahn Therapeutics
Bristol-Myers Squibb
Bristol-Myers Squibb investment in Series C - Autobahn Therapeutics
Pfizer Venture Investments
Pfizer Venture Investments investment in Series C - Autobahn Therapeutics
Official Site Inspections
http://www.autobahntx.com Semrush global rank: 11.52 M Semrush visits lastest month: 156
- Host name: 169.75.82.34.bc.googleusercontent.com
- IP address: 34.82.75.169
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Autobahn Therapeutics"
About Us โ Autobahn Therapeutics
Our mission is to improve life health for people affected by CNS disorders by driving the regenerative power of the human body. Altering the progressive and debilitating course of โฆSee details»
Careers โ Autobahn Therapeutics
Works closely with discovery, clinical development, safety and pharmacovigilance, corporate development and strategic alliance partners. Collaborates across the organization to drive long-term organizational โฆSee details»
Autobahn Therapeutics - Crunchbase Company Profile โฆ
Contact Email [email protected] Phone Number +1 858 722-0037 Autobahn Therapeutics is a biotechnology company developing a portfolio of neuropsychiatric and neuroimmunologic clinical candidates leveraging its โฆSee details»
Autobahn Therapeutics, Inc. | LinkedIn
Autobahntx.com 154 12 Comments Like Comment Share Autobahn Therapeutics, Inc. 4,144 followers 1mo Report this post As we observe World Mental Health Day, Autobahn is committed to raising awareness ...See details»
Autobahn Therapeutics - PitchBook
Autobahn Therapeutics General Information Description. Developer of regenerative medicines and a brain-targeting chemistry for restoring the hopes for people affected by central nervous โฆSee details»
Autobahn Therapeutics Strengthens Management โฆ
Sep 14, 2021 Autobahn Therapeutics is based in San Diego. For more information, visit www.autobahntx.com. Contacts. Alicia Davis, THRUST Strategic Communications [email protected]. Release Summary.See details»
Autobahn Therapeutics - Overview, News & Similar companies
Mar 13, 2024 Autobahn Therapeutics to Present at the Stifel 2024 Virtual CNS Days SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics, a biotechnology company leveraging its โฆSee details»
Autobahn Therapeutics Announces Successful Financing to โฆ
Sep 8, 2022 The companyโs pipeline is led by ABX-002, a thyroid hormone receptor beta agonist, being developed initially for people with treatment-resistant depression. Autobahn โฆSee details»
Autobahn Therapeutics Launches with $76 Million โฆ
Jun 9, 2020 Autobahn Therapeutics is based in San Diego. For more information, visit www.autobahntx.com. Contacts. Alicia Davis, THRUST Strategic Communications [email protected]. Release Summary.See details»
Autobahn Therapeutics - Craft
Autobahn Therapeutics is a company focused on improving life health for people affected by CNS disorders. The company leverages a deep understanding of validated human biology coupled โฆSee details»
Autobahn Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โฆSee details»
Autobahn Therapeutics Announces Successful Financing to โฆ
Sep 8, 2022 SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders, today announced โฆSee details»
Betsy Vaughn โ Autobahn Therapeutics
Ms. Vaughn is a seasoned human resources executive with over 20 years in the biotech and financial services industries. Prior to Autobahn she served at Illumina during an 8-year period โฆSee details»
Autobahn Therapeutics Advances ABX-002, its Lead Oral โฆ
Apr 18, 2023 ABX-002 was Well-tolerated in Healthy Volunteers in Completed Single Ascending Dose Cohorts, Supporting Continued Clinical AdvancementSee details»
Autobahn Therapeutics, Inc. (Autobahn Therapeutics, Inc.) - ่ฏ็ฉ็ฎก โฆ
For more information, visit www.autobahntx.com . About ABX-002 ABX-002 is an orally administered, potent and selective thyroid hormone beta receptor (TRฮฒ) agonist designed to โฆSee details»
Rohan Gandhi, Ph.D. - Autobahn Therapeutics
He has worked across the research and development organization, focusing on the translation of preclinical discoveries to early clinical development success by utilizing a biomarker-driven โฆSee details»
autobahntx.com Reviews: Is this site a scam or legit? - Scam Detector
Organization Domains By Proxy, LLC . Street DomainsByProxy.com 100 S. Mill Ave, Suite 1600 . State Arizona . Country UNITED STATES . ... autobahntx.com is a suspicious website, given โฆSee details»
Autobahn Therapeutics Announces Positive Topline ... - Business โฆ
Nov 7, 2023 SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics, a biotechnology company leveraging its brain-targeting chemistry platform, validated biology and biomarker โฆSee details»
Our Pipeline - Autobahn Therapeutics
Through a deep understanding of human biology, we are developing transformative pipeline of small molecule therapies that unlock validated CNS pharmacology for the treatment of highly โฆSee details»